Working to Eradicate Gynecologic Cancers

Darrell R Fisher, MD

Health Physicist
Dade Moeller Health Group
1835 Terminal Drive
Richland, WA
USA 99354

Papers:
157 Long term safety follow up, dosimetry and immunologic responses in patients enrolled on a phase I trial of intraperitoneal 212Pb labeled trastuzumab